HR 3354 117th Congress House Health Aging Congressional oversight Government studies and investigations Health care costs and insurance Health care quality Health information and medical records Health promotion and preventive care Medical research Medical tests and diagnostic methods Medicare Neurological disorders Public-private cooperation Research administration and funding

CHANGE Act of 2021

Introduced: May 19, 2021 Introduced by: Sánchez, Linda T. Democratic · California See on congress.gov

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

May 20, 2021

Referred to the Subcommittee on Health.

May 19, 2021

Introduced in House

May 19, 2021

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Plain-English summary Congressional Research Service

Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2021 or the CHANGE Act of 2021

This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.

Additionally, the Centers for Medicare & Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.

The Government Accountability Office also must conduct a study of policies that may accelerate progress in Alzheimer's disease research and enhance the quality of care for individuals diagnosed with Alzheimer's disease.

What's happening now May 20, 2021

Referred to the Subcommittee on Health.

Committees of jurisdiction 3

Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Ways and Means Committee
House of Representatives